speb/financial-data huggingface dataset:
Financial ratios for BBBY — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 59.01
Shares outstanding: 95264276
Market cap (USD): 5621544926.76
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BBBY — annual report dated 2022-12-31
Total revenue: 1929334000
Gross profit: 507613000
Operating income: 27008000
Net income: -35236000
Capital expenditures: 14899000
Operating cash flow: -12535000
Depreciation & amortization: 16706000
Net tangible assets: 639657000
Owner earnings: -33429000
Return on net tangible assets (%): -5.226082103377279
Capex to operating income (%): 55.165136255924175
Buffett classification: The Good
Stock price: 19.36
Shares outstanding: 95264276
Book value: 645826000
P/B ratio: 2.855748116923134
Market cap (USD): 1844316383.36
Debt to equity: 0.05338279970146758
Current ratio: 2.16859193688462
Quick ratio: 2.134449780791244
Interest coverage ratio: 13.936016511867905
COGS to revenue (%): 73.6897292018904
R&D to revenue (%): 6.279783593716795
SG&A to revenue (%): 15.299476399628059
Free cash flow (dilution-adjusted): -45752000
Buyback yield (%): 4.343994377691414
Retained earnings: -173829000
Inventory turnover: 217.8548881397487
Receivables turnover: 109.04504606341492
Capitalized R&D asset: 121158000
ROCI (R&D-adjusted, %): 13.329837415065263
FCF margin (%): -2.371388261441513
Rule of 40 score: -2.371388261441513
Financial ratios for BBBY — annual report dated 2023-12-31
Total revenue: 1561122000
Gross profit: 366029000
Operating income: -143980000
Net income: -307842000
Capital expenditures: 44997000
Operating cash flow: -18586000
Depreciation & amortization: 19447000
Net tangible assets: 327718000
Owner earnings: -333392000
Return on net tangible assets (%): -101.73136660177346
Buffett classification: The Gruesome
Stock price: 27.69
Shares outstanding: 95264276
Book value: 359132000
P/B ratio: 7.345120463896284
Market cap (USD): 2637867802.44
Debt to equity: 0.010452981076595792
Current ratio: 1.506370618989221
Quick ratio: 1.4502592568686934
Interest coverage ratio: -81.71396140749148
COGS to revenue (%): 76.55346603276362
R&D to revenue (%): 7.504474346015237
SG&A to revenue (%): 20.175040771957605
Free cash flow (dilution-adjusted): -86601000
Buyback yield (%): 0
Retained earnings: -481671000
Inventory turnover: 91.64823619631902
Receivables turnover: 80.38733264675592
Capitalized R&D asset: 198329860
ROCI (R&D-adjusted, %): -17.658966063465545
Rosenberg metric: -1.168589775334687
FCF margin (%): -5.547356324489694
Revenue growth (%): -19.084927752270993
Rule of 40 score: -24.632284076760687
Financial ratios for BBBY — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 10.08
Shares outstanding: 95264276
Market cap (USD): 960263902.08
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BBBY — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.93
Shares outstanding: 95264276
Market cap (USD): 469652880.67999995
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BBBY — annual report dated 2024-12-31
Total revenue: 1394964000
Gross profit: 290164000
Operating income: -184087000
Net income: -258795000
Capital expenditures: 20359000
Operating cash flow: -174304000
Depreciation & amortization: 19062000
Net tangible assets: 126326000
Owner earnings: -260092000
Return on net tangible assets (%): -205.88952393014898
Buffett classification: The Gruesome
Stock price: 4.93
Shares outstanding: 95264276
Book value: 162732000
P/B ratio: 2.8860511803455986
Market cap (USD): 469652880.67999995
Debt to equity: 0.20072880564363493
Current ratio: 1.0117672695576378
Quick ratio: 0.9604199927955492
Interest coverage ratio: -83.56196096232411
COGS to revenue (%): 79.19917646620272
R&D to revenue (%): 8.214118787294868
SG&A to revenue (%): 22.435202628885044
Free cash flow (dilution-adjusted): -213918000
Buyback yield (%): 0
Retained earnings: -740466000
Inventory turnover: 95.68681794560887
Receivables turnover: 88.02700826654888
Capitalized R&D asset: 233059320
ROCI (R&D-adjusted, %): -45.625732410827275
Rosenberg metric: -0.6475664509961248
FCF margin (%): -15.335019398350063
Revenue growth (%): -10.643498714386192
Rule of 40 score: -25.978518112736253
Financial ratios for BBBY — quarterly report dated 2025-03-31
Total revenue: 231748000
Gross profit: 58132000
Operating income: -23211000
Net income: -39912000
Capital expenditures: 6395000
Operating cash flow: -50921000
Depreciation & amortization: 4844000
Net tangible assets: 104435000
Owner earnings: -41463000
Return on net tangible assets (%): -39.70220711447311
Buffett classification: The Gruesome
Stock price: 5.8
Shares outstanding: 95264276
Book value: 143368000
P/B ratio: 3.853947887952681
Market cap (USD): 552532800.8
Debt to equity: 0.22341108197087217
Current ratio: 0.9530286640116034
Quick ratio: 0.8337545537892863
COGS to revenue (%): 74.91585687902376
R&D to revenue (%): 11.528902083297375
SG&A to revenue (%): 19.678271225641645
Free cash flow (dilution-adjusted): -58410000
Buyback yield (%): 0
Retained earnings: -780378000
Inventory turnover: 7.061005368472426
Receivables turnover: 12.823594510845506
Capitalized R&D asset: 26718000
ROCI (R&D-adjusted, %): -2.929526414029605
FCF margin (%): -25.20410100626543
Rule of 40 score: -25.20410100626543
Financial ratios for BBBY — quarterly report dated 2025-06-30
Total revenue: 282251000
Gross profit: 66969000
Operating income: -17880000
Net income: -19313000
Capital expenditures: 1813000
Operating cash flow: 15829000
Depreciation & amortization: 4080000
Net tangible assets: 92132000
Owner earnings: -17046000
Return on net tangible assets (%): -18.501714930751533
Buffett classification: The Gruesome
Stock price: 6.88
Shares outstanding: 95264276
Book value: 131205000
P/B ratio: 4.99537532014786
Market cap (USD): 655418218.88
Debt to equity: 0.19333866849586526
Current ratio: 0.9091014584242334
Quick ratio: 0.8700647053908781
COGS to revenue (%): 76.27324615324657
R&D to revenue (%): 8.227074483349925
SG&A to revenue (%): 18.52854374298054
Free cash flow (dilution-adjusted): 10630000
Buyback yield (%): 0
Retained earnings: -799691000
Inventory turnover: 25.59833531510107
Receivables turnover: 12.089390499850088
Capitalized R&D asset: 41122060
ROCI (R&D-adjusted, %): -6.152359455972953
Rosenberg metric: 0.3307508047009507
FCF margin (%): 3.7661514042465747
Revenue growth (%): 21.792205326475308
Rule of 40 score: 25.558356730721883
Financial ratios for BBBY — quarterly report dated 2025-09-30
Total revenue: 257187000
Gross profit: 65163000
Operating income: -12452000
Net income: -4521000
Capital expenditures: 12255000
Operating cash flow: -15120000
Depreciation & amortization: 3879000
Net tangible assets: 151102000
Owner earnings: -12897000
Return on net tangible assets (%): -8.535294039787694
Buffett classification: The Gruesome
Stock price: 9.79
Shares outstanding: 95264276
Book value: 202940000
P/B ratio: 4.595630541243716
Market cap (USD): 932637262.04
Debt to equity: 0.1220656351631024
Current ratio: 1.1719652156327418
Quick ratio: 1.135497244552303
COGS to revenue (%): 74.66318282028251
R&D to revenue (%): 8.027233102761803
SG&A to revenue (%): 18.701178519909636
Free cash flow (dilution-adjusted): -30897000
Buyback yield (%): 0.5261423920878623
Retained earnings: -804212000
Inventory turnover: 26.621932621655343
Receivables turnover: 14.860287744843127
Capitalized R&D asset: 45020010
ROCI (R&D-adjusted, %): -5.8618683875037885
Rosenberg metric: -0.07777442831919383
FCF margin (%): -12.013437693196002
Revenue growth (%): -8.880039397557493
Rule of 40 score: -20.893477090753493
Financial ratios for BBBY — quarterly report dated 2025-12-31
Total revenue: 273430000
Gross profit: 67258000
Operating income: -13124000
Net income: -20875000
Capital expenditures: 2349000
Operating cash flow: -6489000
Depreciation & amortization: 3475000
Net tangible assets: 166283000
Owner earnings: -19749000
Return on net tangible assets (%): -11.876740256069471
Buffett classification: The Gruesome
Stock price: 5.46
Shares outstanding: 95264276
Book value: 217944000
P/B ratio: 2.386589889879969
Market cap (USD): 520142946.96
Debt to equity: 0.10126913335535734
Current ratio: 1.2496487046308535
Quick ratio: 1.2227837165488742
COGS to revenue (%): 75.40211388655231
R&D to revenue (%): 7.2018432505577294
SG&A to revenue (%): 18.62524229236002
Free cash flow (dilution-adjusted): -11689000
Buyback yield (%): 0
Retained earnings: -842711000
Inventory turnover: 39.94033320418443
Receivables turnover: 12.894600330110823
Capitalized R&D asset: 41187080
ROCI (R&D-adjusted, %): -5.324948633807165
Rosenberg metric: 0.10147735529183821
FCF margin (%): -4.274951541527996
Revenue growth (%): 6.315638037692419
Rule of 40 score: 2.0406864961644224
Financial ratios for BBBY — annual report dated 2025-12-31
Total revenue: 1044616000
Gross profit: 257522000
Operating income: -61213000
Net income: -84621000
Capital expenditures: 22812000
Operating cash flow: -56701000
Depreciation & amortization: 16278000
Net tangible assets: 166283000
Owner earnings: -91155000
Return on net tangible assets (%): -54.81919378409098
Buffett classification: The Gruesome
Stock price: 5.46
Shares outstanding: 95264276
Book value: 217944000
P/B ratio: 2.386589889879969
Market cap (USD): 520142946.96
Debt to equity: 0.10126913335535734
Current ratio: 1.2496487046308535
Quick ratio: 1.2227837165488742
Interest coverage ratio: -52.140545144804086
COGS to revenue (%): 75.34768757131808
R&D to revenue (%): 8.642027309556813
SG&A to revenue (%): 18.851424829793913
Free cash flow (dilution-adjusted): -90366000
Buyback yield (%): 1.1954406065373748
Retained earnings: -842711000
Inventory turnover: 152.47849670670283
Receivables turnover: 49.262721056354636
Capitalized R&D asset: 205708100
ROCI (R&D-adjusted, %): -17.828667586400424
Rosenberg metric: -0.28487397891503174
FCF margin (%): -8.650642915674277
Revenue growth (%): -25.115200105522433
Rule of 40 score: -33.76584302119671
Financial ratios for BDI.TO — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.283464566929134
Shares outstanding: 68606000
Market cap (USD): 225265370.07874015
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BDI.TO — annual report dated 2022-12-31
Total revenue: 238635294.11764705
Gross profit: 103008823.52941176
Operating income: 32099999.999999996
Net income: 20829411.76470588
Capital expenditures: 37538970.58823529
Operating cash flow: 52050735.294117644
Depreciation & amortization: 25865441.176470585
Net tangible assets: 173385294.11764705
Owner earnings: 9155882.352941178
Return on net tangible assets (%): 5.28065681667826
Capex to operating income (%): 116.94383360820963
Buffett classification: The Gruesome
Stock price: 3.389705882352941
P/E ratio: 11.16470135554928
Shares outstanding: 68606000
Book value: 200399264.70588237
P/B ratio: 1.160454166865412
Market cap (USD): 232554161.76470587
Debt to equity: 0.9138411186491672
Current ratio: 1.4361231569817865
Quick ratio: 1.3711332755131542
Effective tax rate (%): 29.600636198712692
Interest coverage ratio: 5.644685802948021
COGS to revenue (%): 56.83420429895484
SG&A to revenue (%): 18.79128870045356
Free cash flow (dilution-adjusted): 9019852.94117647
Buyback yield (%): 4.186880437656427
Retained earnings: -115104411.76470588
Inventory turnover: 41.02580071174377
Receivables turnover: 4.493264478256656
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.523498006073118
FCF margin (%): 3.779764839282193
Rule of 40 score: 3.779764839282193
Financial ratios for BDI.TO — annual report dated 2023-12-31
Total revenue: 298109848.4848485
Gross profit: 132160606.06060605
Operating income: 41144696.96969697
Net income: 23838636.363636363
Capital expenditures: 49477272.72727273
Operating cash flow: 100753787.87878788
Depreciation & amortization: 33468939.39393939
Net tangible assets: 195556818.1818182
Owner earnings: 7830303.030303024
Return on net tangible assets (%): 4.004106378445384
Capex to operating income (%): 120.25188267570105
Buffett classification: The Gruesome
Stock price: 5.992424242424242
P/E ratio: 17.245795913178885
Shares outstanding: 68606000
Book value: 222698484.84848487
P/B ratio: 1.846066702498962
Market cap (USD): 411116257.57575756
Debt to equity: 0.7202971812683271
Current ratio: 1.09674340620365
Quick ratio: 1.039014638550332
Effective tax rate (%): 22.395679195028116
Interest coverage ratio: 4.165592882343918
COGS to revenue (%): 55.66714527134343
SG&A to revenue (%): 19.22262741261229
Free cash flow (dilution-adjusted): 44576515.15151515
Buyback yield (%): 0.6230265987210799
Retained earnings: -99721969.69696969
Inventory turnover: 48.939454870420015
Receivables turnover: 6.288634257039665
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.526507444255785
FCF margin (%): 14.953050151840507
Revenue growth (%): 24.92278210023725
Rule of 40 score: 39.87583225207776
Financial ratios for BDI.TO — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 7.103703703703703
Shares outstanding: 68606000
Market cap (USD): 487356696.29629624
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BDI.TO — quarterly report dated 2024-12-31
Total revenue: 92820279.72027972
Gross profit: 38636363.63636364
Operating income: 13997202.797202798
Net income: 6916783.216783217
Capital expenditures: 9733566.433566434
Operating cash flow: 21123076.923076924
Depreciation & amortization: 10164335.664335664
Net tangible assets: 204125874.12587413
Owner earnings: 7347552.447552448
Return on net tangible assets (%): 3.599520383693046
Capex to operating income (%): 69.53936850519584
Buffett classification: The Good
Stock price: 6.454545454545455
P/E ratio: 16.00529218481448
Shares outstanding: 68606000
Book value: 228709090.90909094
P/B ratio: 1.936173781699658
Market cap (USD): 442820545.4545455
Debt to equity: 0.8031059091159258
Current ratio: 1.3020478634118267
Quick ratio: 1.2509471967771328
Effective tax rate (%): 38.84629652528751
Interest coverage ratio: 6.25109306683323
COGS to revenue (%): 58.37508381487648
SG&A to revenue (%): 15.684117740124911
Free cash flow (dilution-adjusted): 9955244.755244756
Buyback yield (%): 0.16044637444728513
Retained earnings: -79453846.15384616
Inventory turnover: 18.179962458939464
Receivables turnover: 1.8482371616352902
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.0092550830792546
FCF margin (%): 10.725290621021148
Rule of 40 score: 10.725290621021148
Financial ratios for BDI.TO — annual report dated 2024-12-31
Total revenue: 281815384.61538464
Gross profit: 128510489.51048952
Operating income: 38316083.91608392
Net income: 19077622.377622377
Capital expenditures: 73911188.81118882
Operating cash flow: 77874825.17482518
Depreciation & amortization: 34261538.461538464
Net tangible assets: 204125874.12587413
Owner earnings: -20572027.972027972
Return on net tangible assets (%): -10.078108941418295
Capex to operating income (%): 192.89859833552345
Buffett classification: The Gruesome
Stock price: 6.454545454545455
P/E ratio: 23.2115164400132
Shares outstanding: 68606000
Book value: 228709090.90909094
P/B ratio: 1.936173781699658
Market cap (USD): 442820545.4545455
Debt to equity: 0.8031059091159258
Current ratio: 1.3020478634118267
Quick ratio: 1.2509471967771328
Effective tax rate (%): 29.6065023867888
Interest coverage ratio: 3.707171853856563
COGS to revenue (%): 54.39905110720702
SG&A to revenue (%): 19.87687222701962
Free cash flow (dilution-adjusted): -1953846.1538461542
Buyback yield (%): 0.979259810972062
Retained earnings: -79453846.15384616
Inventory turnover: 51.43735335523229
Receivables turnover: 5.611507185028406
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.237565173465153
FCF margin (%): -0.6933071295993013
Revenue growth (%): -5.465926051179094
Rule of 40 score: -6.159233180778395
Financial ratios for BDI.TO — quarterly report dated 2025-03-31
Total revenue: 71488111.88811189
Gross profit: 30993006.993006993
Operating income: 7874825.174825175
Net income: 4329370.62937063
Capital expenditures: 11441258.741258742
Operating cash flow: 25090209.790209793
Depreciation & amortization: 8646853.146853147
Net tangible assets: 204497202.7972028
Owner earnings: 1534965.0349650346
Return on net tangible assets (%): 0.7506044160844778
Capex to operating income (%): 145.2890507059764
Buffett classification: The Gruesome
Stock price: 6.167832167832168
P/E ratio: 24.434861896301083
Shares outstanding: 68606000
Book value: 228596503.49650353
P/B ratio: 1.8510794663697294
Market cap (USD): 423150293.70629376
Debt to equity: 0.7879306072629269
Current ratio: 1.18165509710631
Quick ratio: 1.18165509710631
Effective tax rate (%): 17.221553683647546
Interest coverage ratio: 2.977525118984664
COGS to revenue (%): 56.645928708377355
SG&A to revenue (%): 20.24298626599366
Free cash flow (dilution-adjusted): 12163636.363636363
Buyback yield (%): 0.7312781393349107
Retained earnings: -76875524.47552449
Receivables turnover: 1.3852220219786175
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.6971759450441135
FCF margin (%): 17.01490785303439
Revenue growth (%): -22.982227479225212
Rule of 40 score: -5.967319626190822
Financial ratios for BDI.TO — quarterly report dated 2025-06-30
Total revenue: 76908029.19708028
Gross profit: 34880291.97080292
Operating income: 9937956.20437956
Net income: 6956934.3065693425
Capital expenditures: 23027737.22627737
Operating cash flow: 20819708.02919708
Depreciation & amortization: 8786861.313868612
Net tangible assets: 210547445.25547445
Owner earnings: -7283941.605839416
Return on net tangible assets (%): -3.4595250476685733
Capex to operating income (%): 231.7150201983107
Buffett classification: The Gruesome
Stock price: 7.13868613138686
P/E ratio: 26.90514360095867
Shares outstanding: 68606000
Book value: 235175182.48175186
P/B ratio: 2.082518638070703
Market cap (USD): 489756700.72992694
Debt to equity: 0.8289673794965701
Current ratio: 1.1644936749779107
Quick ratio: 1.1644936749779107
Effective tax rate (%): 24.56667985753859
Interest coverage ratio: 3.771468144044321
COGS to revenue (%): 54.64674841501841
SG&A to revenue (%): 21.00622603545803
Free cash flow (dilution-adjusted): -3973722.627737226
Buyback yield (%): 0.5407123942428855
Retained earnings: -75097810.21897809
Receivables turnover: 1.347469115277387
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.0360248540088675
FCF margin (%): -5.166850157549068
Revenue growth (%): 7.5815644948789025
Rule of 40 score: 2.4147143373298343
Financial ratios for BDI.TO — quarterly report dated 2025-12-31
Total revenue: 105112408.75912409
Gross profit: 44037956.20437956
Operating income: 14095620.437956203
Net income: 6692700.729927007
Capital expenditures: 19800000
Operating cash flow: 33656204.37956204
Depreciation & amortization: 11509489.05109489
Net tangible assets: 232940145.98540145
Owner earnings: -1597810.2189781033
Return on net tangible assets (%): -0.6859316637838114
Capex to operating income (%): 140.46916265341
Buffett classification: The Gruesome
Stock price: 10.642335766423358
P/E ratio: 29.32737303617099
Shares outstanding: 68606000
Book value: 292350364.9635036
P/B ratio: 2.497442025367023
Market cap (USD): 730128087.5912409
Debt to equity: 0.9549885149305902
Current ratio: 1.418671461432604
Quick ratio: 1.3489598505318774
Effective tax rate (%): 37.94247038917089
Interest coverage ratio: 7.742983159582999
COGS to revenue (%): 58.10394155717896
SG&A to revenue (%): 17.346045943168246
Free cash flow (dilution-adjusted): 6247445.255474452
Buyback yield (%): 0
Retained earnings: -64545255.47445255
Inventory turnover: 12.056484149855907
Receivables turnover: 1.5410892201663045
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.094695737064758
FCF margin (%): 5.943584900419433
Revenue growth (%): 36.67286739303748
Rule of 40 score: 42.61645229345691
Financial ratios for BDI.TO — annual report dated 2025-12-31
Total revenue: 333518248.17518246
Gross profit: 147889781.0218978
Operating income: 43447445.25547445
Net income: 27208029.197080288
Capital expenditures: 65123357.66423357
Operating cash flow: 95559124.08759123
Depreciation & amortization: 38364963.50364963
Net tangible assets: 232940145.98540145
Owner earnings: 449635.0364963487
Return on net tangible assets (%): 0.19302599583865965
Capex to operating income (%): 149.88995850343565
Buffett classification: The Gruesome
Stock price: 10.642335766423358
P/E ratio: 26.83502293762576
Shares outstanding: 68606000
Book value: 292350364.9635036
P/B ratio: 2.497442025367023
Market cap (USD): 730128087.5912409
Debt to equity: 0.9549885149305902
Current ratio: 1.418671461432604
Quick ratio: 1.3489598505318774
Effective tax rate (%): 27.643838807360815
Interest coverage ratio: 4.5392358727979865
COGS to revenue (%): 55.65766436137617
SG&A to revenue (%): 19.75225422393417
Free cash flow (dilution-adjusted): 14216788.321167883
Buyback yield (%): 0.8050782170527663
Retained earnings: -64545255.47445255
Inventory turnover: 36.64423631123919
Receivables turnover: 4.889825883158717
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.456557110315653
FCF margin (%): 4.262671802503721
Revenue growth (%): 18.346359490047266
Rule of 40 score: 22.609031292550988
Financial ratios for BPCL.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.9610971910853225
Shares outstanding: 4272584874
Market cap (USD): 8378954195.075037
Buyback yield (%): 0
Retained earnings: 1166687326.915469
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BPCL.NS — annual report dated 2023-03-31
Total revenue: 56791440925.70037
Gross profit: 2481732034.1047506
Operating income: 904186358.0998783
Net income: 259567600.48721075
Capital expenditures: 1036042630.9378808
Operating cash flow: 1518343483.5566382
Depreciation & amortization: 775739342.2655299
Net tangible assets: 4967364190.01218
Owner earnings: -735688.1851401329
Return on net tangible assets (%): -0.014810433803492248
Capex to operating income (%): 114.58286465580996
Buffett classification: The Gruesome
Stock price: 1.7660170523751524
P/E ratio: 29.06933581479834
Shares outstanding: 4272584874
Book value: 6519166869.671135
P/B ratio: 1.1574266920988907
Market cap (USD): 7545457745.204142
Debt to equity: 1.2962064826737831
Current ratio: 0.7485174859789081
Quick ratio: 0.24005461116988625
Effective tax rate (%): 24.46112018942764
Interest coverage ratio: 1.8887588447671801
COGS to revenue (%): 95.63009496914935
SG&A to revenue (%): 0.1965629610044213
Free cash flow (dilution-adjusted): 477098660.17052376
Buyback yield (%): 0
Retained earnings: 1141813641.900122
Inventory turnover: 11.712429657683813
Receivables turnover: 69.34458444505918
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.553864821776075
FCF margin (%): 0.8400890211514562
Rule of 40 score: 0.8400890211514562
Financial ratios for BPCL.NS — annual report dated 2024-03-31
Total revenue: 53563528000.95935
Gross profit: 6898851181.196786
Operating income: 4517776711.835952
Net income: 3220870607.986569
Capital expenditures: 1055817244.2738937
Operating cash flow: 4313422472.718552
Depreciation & amortization: 811999040.6523564
Net tangible assets: 7445510253.027941
Owner earnings: 2977052404.3650317
Return on net tangible assets (%): 39.98453165992652
Capex to operating income (%): 23.370283916595483
Buffett classification: The Great
Stock price: 3.222528790786948
P/E ratio: 4.2747845049735815
Shares outstanding: 4272584874
Book value: 9070045569.013073
P/B ratio: 1.5180218955662867
Market cap (USD): 13768527767.545824
Debt to equity: 0.7218744046250477
Current ratio: 0.8122077737107426
Quick ratio: 0.28260416416821355
Effective tax rate (%): 25.792911839498
Interest coverage ratio: 9.187798293341398
COGS to revenue (%): 87.12024499007379
SG&A to revenue (%): 0.23138528529108066
Free cash flow (dilution-adjusted): 3164707998.5609784
Buyback yield (%): 0
Retained earnings: 3030640364.5521045
Inventory turnover: 9.084311304499261
Receivables turnover: 53.54407260582856
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 30.99842456088759
FCF margin (%): 5.908326274744817
Revenue growth (%): -5.683801770347866
Rule of 40 score: 0.2245245043969506
Financial ratios for BPCL.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 7463156951.743908
Buffett classification: The Gruesome
Stock price: 4.067247969421882
Shares outstanding: 4272584874
Book value: 9210226946.966076
P/B ratio: 1.8867789309668959
Market cap (USD): 17377662152.95915
Debt to equity: 0.7636087659882852
Current ratio: 0.7928970812011562
Quick ratio: 0.2930514821817433
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BPCL.NS — quarterly report dated 2024-12-31
Total revenue: 13191032754.400278
Gross profit: 1565213894.3932858
Operating income: 666251311.3416482
Net income: 443634456.2303299
Capital expenditures: 0
Owner earnings: 443634456.2303299
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 3.1376617321366127
P/E ratio: 7.554601467596179
Shares outstanding: 4272584874
Market cap (USD): 13405926056.455532
Effective tax rate (%): 28.633763175116307
Interest coverage ratio: 6.6365209112230925
COGS to revenue (%): 88.13425814691303
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BPCL.NS — quarterly report dated 2025-03-31
Total revenue: 13003297872.340425
Gross profit: 1615747018.9385083
Operating income: 672714519.5230302
Net income: 513424129.0624269
Capital expenditures: 0
Net tangible assets: 7744828150.572831
Owner earnings: 513424129.0624269
Return on net tangible assets (%): 6.6292514059779695
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 3.0501808845839657
P/E ratio: 6.345707171104156
Shares outstanding: 4272584874
Book value: 9514154781.38882
P/B ratio: 1.3697650511141921
Market cap (USD): 13032156710.437391
Debt to equity: 0.750768086338262
Current ratio: 0.803249294159167
Quick ratio: 0.3040302408681842
Effective tax rate (%): 25.521303224143427
Interest coverage ratio: 6.264792657833713
COGS to revenue (%): 87.57432895253906
Buyback yield (%): 0
Retained earnings: 1945053776.0112226
Inventory turnover: 2.1519651193334215
Receivables turnover: 11.910316758361192
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.505825767115585
Revenue growth (%): -1.4232007876504424
Rule of 40 score: -1.4232007876504424
Financial ratios for BPCL.NS — annual report dated 2025-03-31
Total revenue: 51469705400.981995
Gross profit: 5578473228.898761
Operating income: 2121193593.640402
Net income: 1559101005.377601
Capital expenditures: 1555199906.4765022
Operating cash flow: 2768037175.590367
Depreciation & amortization: 848338788.8707037
Net tangible assets: 7744828150.572831
Owner earnings: 852239887.7718022
Return on net tangible assets (%): 11.003987063402665
Capex to operating income (%): 73.31720740337808
Buffett classification: The Good
Stock price: 3.0501808845839657
P/E ratio: 8.358763585866019
Shares outstanding: 4272584874
Book value: 9514154781.38882
P/B ratio: 1.3697650511141921
Market cap (USD): 13032156710.437391
Debt to equity: 0.750768086338262
Current ratio: 0.803249294159167
Quick ratio: 0.3040302408681842
Effective tax rate (%): 26.65091875065311
Interest coverage ratio: 5.052204686699485
COGS to revenue (%): 89.1616375391332
SG&A to revenue (%): 0.26635588293105994
Free cash flow (dilution-adjusted): 997740238.4849193
Buyback yield (%): 0
Retained earnings: 1945053776.0112226
Inventory turnover: 8.672306467729396
Receivables turnover: 47.14346320476112
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 14.20770397232109
FCF margin (%): 1.9384999986144926
Revenue growth (%): -3.9090453488049826
Rule of 40 score: -1.97054535019049
Financial ratios for BPCL.NS — quarterly report dated 2025-06-30
Total revenue: 13170073718.698807
Gross profit: 1738553709.337702
Operating income: 911419377.4865435
Net income: 800259770.652937
Capital expenditures: 0
Owner earnings: 800259770.652937
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 3.6457992043061083
P/E ratio: 8.864066366379483
Shares outstanding: 4272584874
Market cap (USD): 15576986533.959515
Effective tax rate (%): 22.911869102730144
Interest coverage ratio: 10.279373919469997
COGS to revenue (%): 86.79921049440055
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 1.2825657613606891
Rule of 40 score: 1.2825657613606891
Financial ratios for BPCL.NS — quarterly report dated 2025-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.648252536640361
P/E ratio: 8.8700311766751
Shares outstanding: 4272584874
Market cap (USD): 15587468604.581738
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BPCL.NS — quarterly report dated 2025-12-31
Total revenue: 13259377297.538153
Gross profit: 1965302439.5677843
Operating income: 1081426980.0601537
Net income: 800757491.3668264
Capital expenditures: 0
Owner earnings: 800757491.3668264
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 4.160298540715162
P/E ratio: 8.406583739493648
Shares outstanding: 4272584874
Market cap (USD): 17775228616.383873
Effective tax rate (%): 26.175826906941325
Interest coverage ratio: 14.766770101305102
COGS to revenue (%): 85.17801857910267
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CDNA — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 45.48
Shares outstanding: 51659481
Market cap (USD): 2349473195.8799996
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CDNA — annual report dated 2022-12-31
Total revenue: 321793000
Gross profit: 209581000
Operating income: -77231000
Net income: -76613000
Capital expenditures: 24334000
Operating cash flow: -25239000
Depreciation & amortization: 16007000
Net tangible assets: 350337000
Owner earnings: -84940000
Return on net tangible assets (%): -24.24522673882576
Buffett classification: The Gruesome
Stock price: 11.41
Shares outstanding: 51659481
Book value: 430911000
P/B ratio: 1.367880323802363
Market cap (USD): 589434678.21
Debt to equity: 0.09049896614382089
Current ratio: 5.104955577492596
Quick ratio: 4.851819677525502
COGS to revenue (%): 34.8708641890905
R&D to revenue (%): 28.088864580646565
SG&A to revenue (%): 61.040482546233136
Free cash flow (dilution-adjusted): -96126000
Buyback yield (%): 0.10891792148192414
Retained earnings: -460444000
Inventory turnover: 5.834650582362729
Receivables turnover: 4.852711424779828
Capitalized R&D asset: 90388000
ROCI (R&D-adjusted, %): -3.0448890451689135
FCF margin (%): -29.87199845863645
Rule of 40 score: -29.87199845863645
Financial ratios for CDNA — annual report dated 2023-12-31
Total revenue: 280324000
Gross profit: 178258000
Operating income: -107063000
Net income: -190284000
Capital expenditures: 9240000
Operating cash flow: -18388000
Depreciation & amortization: 19824000
Net tangible assets: 175291000
Owner earnings: -179700000
Return on net tangible assets (%): -102.51524607652418
Buffett classification: The Gruesome
Stock price: 12
Shares outstanding: 51659481
Book value: 261328000
P/B ratio: 2.3721674370905528
Market cap (USD): 619913772
Debt to equity: 0.1309503765382967
Current ratio: 4.0182523824162315
Quick ratio: 3.7688543908187313
COGS to revenue (%): 36.4100112726702
R&D to revenue (%): 29.402049057519157
SG&A to revenue (%): 72.38053109972746
Free cash flow (dilution-adjusted): -76714000
Buyback yield (%): 4.442714655482763
Retained earnings: -678269000
Inventory turnover: 5.241949566021263
Receivables turnover: 5.489982569867413
Capitalized R&D asset: 142980960
ROCI (R&D-adjusted, %): -15.467292201362875
Rosenberg metric: -0.34653936363234056
FCF margin (%): -27.366190550933922
Revenue growth (%): -12.886855835894503
Rule of 40 score: -40.25304638682842
Financial ratios for CDNA — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 31.23
Shares outstanding: 51659481
Market cap (USD): 1613325591.63
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CDNA — annual report dated 2024-12-31
Total revenue: 333785000
Gross profit: 224089000
Operating income: -55535000
Net income: 52549000
Capital expenditures: 6484000
Operating cash flow: 38048000
Depreciation & amortization: 19757000
Net tangible assets: 299913000
Owner earnings: 65822000
Return on net tangible assets (%): 21.94703130574533
Buffett classification: The Gruesome
Stock price: 21.41
P/E ratio: 21.047583935184306
Shares outstanding: 51659481
Book value: 378433000
P/B ratio: 2.922656026852838
Market cap (USD): 1106029488.21
Debt to equity: 0.07495646521312888
Current ratio: 3.936758008750042
Quick ratio: 3.7185328574145977
Effective tax rate (%): 0.5864658809285079
COGS to revenue (%): 32.86426891561934
R&D to revenue (%): 21.72356457000764
SG&A to revenue (%): 62.0501220845754
Free cash flow (dilution-adjusted): -34842000
Buyback yield (%): 0.04719584835344722
Retained earnings: -626242000
Inventory turnover: 5.6245705788853
Receivables turnover: 5.16655057658076
Capitalized R&D asset: 157560110
ROCI (R&D-adjusted, %): -11.586814806282057
Rosenberg metric: 0.5560597420560294
FCF margin (%): -10.43845589226598
Revenue growth (%): 19.07114624505929
Rule of 40 score: 8.63269035279331
Financial ratios for CDNA — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 21.41
Shares outstanding: 51659481
Market cap (USD): 1106029488.21
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CDNA — quarterly report dated 2025-03-31
Total revenue: 84685000
Gross profit: 56270000
Operating income: -8014000
Net income: -10353000
Capital expenditures: 1630000
Operating cash flow: -26584000
Depreciation & amortization: 4940000
Net tangible assets: 301766000
Owner earnings: -7043000
Return on net tangible assets (%): -2.333927612786066
Buffett classification: The Gruesome
Stock price: 17.75
Shares outstanding: 51659481
Book value: 379349000
P/B ratio: 2.4171825620998075
Market cap (USD): 916955787.75
Debt to equity: 0.07981304814300288
Current ratio: 4.106737488860747
Quick ratio: 3.837882838516017
COGS to revenue (%): 33.55375804451792
R&D to revenue (%): 21.87400366062467
SG&A to revenue (%): 54.03554348467851
Free cash flow (dilution-adjusted): -37145000
Buyback yield (%): 0
Retained earnings: -636595000
Inventory turnover: 1.2392603253521741
Receivables turnover: 1.1846541232426384
Capitalized R&D asset: 18524000
ROCI (R&D-adjusted, %): 1.025197180589516
FCF margin (%): -43.86254944795419
Rule of 40 score: -43.86254944795419
Financial ratios for CDNA — quarterly report dated 2025-06-30
Total revenue: 86679000
Gross profit: 58021000
Operating income: -10771000
Net income: -8568000
Capital expenditures: 1007000
Operating cash flow: 9895000
Depreciation & amortization: 5053000
Net tangible assets: 250997000
Owner earnings: -4522000
Return on net tangible assets (%): -1.8016151587469171
Buffett classification: The Gruesome
Stock price: 19.54
Shares outstanding: 51659481
Book value: 327370000
P/B ratio: 3.08344154546843
Market cap (USD): 1009426258.74
Debt to equity: 0.08895744875828573
Current ratio: 3.2978750804893755
Quick ratio: 2.9982936252414683
COGS to revenue (%): 33.062218068967105
R&D to revenue (%): 19.4164676565258
SG&A to revenue (%): 59.947622838288396
Free cash flow (dilution-adjusted): -536000
Buyback yield (%): 4.95330882935537
Retained earnings: -695161000
Inventory turnover: 1.0266165144187713
Receivables turnover: 1.286764050948606
Capitalized R&D asset: 29241080
ROCI (R&D-adjusted, %): -1.505494208076215
Rosenberg metric: 0.0945260202979918
FCF margin (%): -0.6183735391501979
Revenue growth (%): 2.3546082541182027
Rule of 40 score: 1.7362347149680049
Financial ratios for CDNA — quarterly report dated 2025-09-30
Total revenue: 100055000
Gross profit: 69401000
Operating income: -246000
Net income: 1675000
Capital expenditures: 1980000
Operating cash flow: 37358000
Depreciation & amortization: 5163000
Net tangible assets: 237358000
Owner earnings: 4858000
Return on net tangible assets (%): 2.0466973938101938
Buffett classification: The Gruesome
Stock price: 14.54
P/E ratio: 112.1087841402985
Shares outstanding: 51659481
Book value: 311140000
P/B ratio: 2.414118576010799
Market cap (USD): 751128853.74
Debt to equity: 0.0888474641640419
Current ratio: 3.031783853640806
Quick ratio: 2.7457695569645812
Effective tax rate (%): -0.9036144578313252
COGS to revenue (%): 30.637149567737744
R&D to revenue (%): 16.759782119834092
SG&A to revenue (%): 52.84893308680226
Free cash flow (dilution-adjusted): 26960000
Buyback yield (%): 3.403277596475947
Retained earnings: -719047000
Inventory turnover: 1.082109573566789
Receivables turnover: 2.091275813059109
Capitalized R&D asset: 34158020
ROCI (R&D-adjusted, %): -0.23170512490911163
Rosenberg metric: 0.6761734997029115
FCF margin (%): 26.945180150916997
Revenue growth (%): 15.431650111330312
Rule of 40 score: 42.37683026224731
Financial ratios for CDNA — annual report dated 2025-12-31
Total revenue: 379805000
Gross profit: 256566000
Operating income: -25071000
Net income: -21354000
Capital expenditures: 6588000
Operating cash flow: 42032000
Depreciation & amortization: 20416000
Net tangible assets: 230805000
Owner earnings: -7526000
Return on net tangible assets (%): -3.2607612486731226
Buffett classification: The Gruesome
Stock price: 18.84
Shares outstanding: 51659481
Book value: 303101000
P/B ratio: 3.211024120804616
Market cap (USD): 973264622.04
Debt to equity: 0.08642003820508676
Current ratio: 2.861823726474418
Quick ratio: 2.564602833643112
COGS to revenue (%): 32.44796671976409
R&D to revenue (%): 18.806756098524243
SG&A to revenue (%): 55.34629612564343
Free cash flow (dilution-adjusted): 580000
Buyback yield (%): 9.017896881532065
Retained earnings: -735359000
Inventory turnover: 4.614828683767085
Receivables turnover: 8.909754152200431
Capitalized R&D asset: 147209630
ROCI (R&D-adjusted, %): -6.182753147549129
Rosenberg metric: 0.44789684181492206
FCF margin (%): 0.15270994326035728
Revenue growth (%): 13.787318183860869
Rule of 40 score: 13.940028127121225
Financial ratios for CDNA — quarterly report dated 2025-12-31
Total revenue: 108386000
Gross profit: 72874000
Operating income: -6040000
Net income: -4108000
Capital expenditures: 1971000
Operating cash flow: 21363000
Depreciation & amortization: 5260000
Net tangible assets: 230805000
Owner earnings: -819000
Return on net tangible assets (%): -0.3548449990251511
Buffett classification: The Gruesome
Stock price: 18.84
Shares outstanding: 51659481
Book value: 303101000
P/B ratio: 3.211024120804616
Market cap (USD): 973264622.04
Debt to equity: 0.08642003820508676
Current ratio: 2.861823726474418
Quick ratio: 2.564602833643112
COGS to revenue (%): 32.76437916336058
R&D to revenue (%): 17.812263576476667
SG&A to revenue (%): 54.996032697949914
Free cash flow (dilution-adjusted): 11301000
Buyback yield (%): 1.2540268826804628
Retained earnings: -735359000
Inventory turnover: 1.3297884291331212
Receivables turnover: 2.5426011072534482
Capitalized R&D asset: 36095130
ROCI (R&D-adjusted, %): -1.2153864869218822
Rosenberg metric: 0.20710835470212893
FCF margin (%): 10.42662336464119
Revenue growth (%): 8.326420468742192
Rule of 40 score: 18.75304383338338
Financial ratios for CECO — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 6.23
Shares outstanding: 58403031
Market cap (USD): 363850883.13
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CECO — annual report dated 2022-12-31
Total revenue: 422627000
Gross profit: 128225000
Operating income: 27943000
Net income: 18263000
Capital expenditures: 3376000
Operating cash flow: 29649000
Depreciation & amortization: 10614000
Net tangible assets: -14732000
Owner earnings: 25501000
Return on net tangible assets (%): -173.09937550909584
Capex to operating income (%): 12.081737823426261
Buffett classification: The Great
Stock price: 11.68
P/E ratio: 37.35133341072113
Shares outstanding: 58403031
Book value: 218148000
P/B ratio: 3.1269936102095826
Market cap (USD): 682147402.08
Debt to equity: 0.5633102297522783
Current ratio: 1.6404771642808453
Quick ratio: 1.4596591683708249
Effective tax rate (%): 22.905145848284015
Interest coverage ratio: 5.156486436611921
COGS to revenue (%): 69.66000752436545
SG&A to revenue (%): 22.117138753558102
Free cash flow (dilution-adjusted): 22378000
Buyback yield (%): 1.0291030910027152
Retained earnings: -19298000
Inventory turnover: 11.098620221669306
Receivables turnover: 2.742514698057131
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.804849436206256
FCF margin (%): 5.294976421288749
Rule of 40 score: 5.294976421288749
Financial ratios for CECO — annual report dated 2023-12-31
Total revenue: 544845000
Gross profit: 171016000
Operating income: 37077000
Net income: 14501000
Capital expenditures: 8384000
Operating cash flow: 44647000
Depreciation & amortization: 12507000
Net tangible assets: -38714000
Owner earnings: 18624000
Return on net tangible assets (%): -48.10662809319626
Capex to operating income (%): 22.612401219084607
Buffett classification: The Great
Stock price: 20.28
P/E ratio: 81.67805452589477
Shares outstanding: 58403031
Book value: 237491000
P/B ratio: 4.9871930670214875
Market cap (USD): 1184413468.68
Debt to equity: 0.6546690190365109
Current ratio: 1.3856656130296496
Quick ratio: 1.2178271444467421
Effective tax rate (%): 32.631823461091756
Interest coverage ratio: 2.763640429338104
COGS to revenue (%): 68.61199056612432
SG&A to revenue (%): 22.564949664583505
Free cash flow (dilution-adjusted): 31730000
Buyback yield (%): 0
Retained earnings: -6387000
Inventory turnover: 10.966264777494207
Receivables turnover: 3.0386153357091468
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.334944673137203
FCF margin (%): 5.823674623057934
Revenue growth (%): 28.91864457311057
Rule of 40 score: 34.7423191961685
Financial ratios for CECO — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 28.2
Shares outstanding: 58403031
Market cap (USD): 1646965474.2
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CECO — annual report dated 2024-12-31
Total revenue: 557933000
Gross profit: 196147000
Operating income: 39616000
Net income: 14421000
Capital expenditures: 17368000
Operating cash flow: 24828000
Depreciation & amortization: 14523000
Net tangible assets: -105574000
Owner earnings: 11576000
Return on net tangible assets (%): -10.964820883929756
Capex to operating income (%): 43.84087237479806
Buffett classification: The Good
Stock price: 30.23
P/E ratio: 122.42726767422509
Shares outstanding: 58403031
Book value: 251893000
P/B ratio: 7.009022192478553
Market cap (USD): 1765523627.13
Debt to equity: 0.9729210418709532
Current ratio: 1.352768308932323
Quick ratio: 1.1785524519541244
Effective tax rate (%): 18.483974902492793
Interest coverage ratio: 3.042703533026114
COGS to revenue (%): 64.84398664355756
SG&A to revenue (%): 26.293121217063696
Free cash flow (dilution-adjusted): -54000
Buyback yield (%): 0.28320210067808044
Retained earnings: 6570000
Inventory turnover: 8.487847222222221
Receivables turnover: 2.431493805047481
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.6918745643516875
FCF margin (%): -0.009678581478421244
Revenue growth (%): 2.4021510704879367
Rule of 40 score: 2.3924724890095157
Financial ratios for CECO — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 30.23
Shares outstanding: 58403031
Market cap (USD): 1765523627.13
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CECO — quarterly report dated 2025-03-31
Total revenue: 176697000
Gross profit: 62162000
Operating income: 5511000
Net income: 36442000
Capital expenditures: 3385000
Operating cash flow: -11696000
Depreciation & amortization: 5115000
Net tangible assets: -107787000
Owner earnings: 38172000
Return on net tangible assets (%): -35.414289292771855
Capex to operating income (%): 61.422609326800945
Buffett classification: The Good
Stock price: 22.8
P/E ratio: 9.13498920750782
Shares outstanding: 58403031
Book value: 290051000
P/B ratio: 4.59087921365553
Market cap (USD): 1331589106.8
Debt to equity: 1.2544138789385315
Current ratio: 1.7079611413647875
Quick ratio: 1.5181199193554173
Effective tax rate (%): 33.812818976007556
Interest coverage ratio: 0.8864404053401962
COGS to revenue (%): 64.8200026033266
SG&A to revenue (%): 30.301589727046867
Free cash flow (dilution-adjusted): -18437000
Buyback yield (%): 0
Retained earnings: 42554000
Inventory turnover: 2.1643455091743986
Receivables turnover: 0.7495418681598371
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.8124232502531912
FCF margin (%): -10.434246195464553
Rule of 40 score: -10.434246195464553
Financial ratios for CECO — quarterly report dated 2025-06-30
Total revenue: 185391000
Gross profit: 67108000
Operating income: 18093000
Net income: 10106000
Capital expenditures: 1047000
Operating cash flow: -7667000
Depreciation & amortization: 5042000
Net tangible assets: -106216000
Owner earnings: 14101000
Return on net tangible assets (%): -13.275777660616104
Capex to operating income (%): 5.78676836345548
Buffett classification: The Great
Stock price: 28.31
P/E ratio: 35.52010414217582
Shares outstanding: 58403031
Book value: 303219000
P/B ratio: 5.452790912211965
Market cap (USD): 1653389807.61
Debt to equity: 0.8730224689086106
Current ratio: 1.3436911256512358
Quick ratio: 1.1339203957408739
Effective tax rate (%): 30.861325853458304
Interest coverage ratio: 3.693956717027358
COGS to revenue (%): 63.80191055660739
SG&A to revenue (%): 26.331375309481043
Free cash flow (dilution-adjusted): -11592000
Buyback yield (%): 0
Retained earnings: 52064000
Inventory turnover: 1.9782412362857908
Receivables turnover: 0.7334665295141636
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.0585904416724286
FCF margin (%): -6.252730715083256
Revenue growth (%): 4.920287271430754
Rule of 40 score: -1.332443443652502
Financial ratios for CECO — quarterly report dated 2025-09-30
Total revenue: 197599000
Gross profit: 64579000
Operating income: 10453000
Net income: 1807000
Capital expenditures: 4241000
Operating cash flow: 15263000
Depreciation & amortization: 8569000
Net tangible assets: -93757000
Owner earnings: 6135000
Return on net tangible assets (%): -6.543511417814137
Capex to operating income (%): 40.57208456902325
Buffett classification: The Good
Stock price: 51.2
P/E ratio: 61.83921388067419
Shares outstanding: 58403031
Book value: 313567000
P/B ratio: 9.536192224309318
Market cap (USD): 2990235187.2000003
Debt to equity: 0.7907496643460569
Current ratio: 1.3258238626839653
Quick ratio: 1.1323477153106039
Effective tax rate (%): 21.09170305676856
Interest coverage ratio: 2.068262762168579
COGS to revenue (%): 67.31815444410144
SG&A to revenue (%): 23.802752038218816
Free cash flow (dilution-adjusted): 7749000
Buyback yield (%): 0
Retained earnings: 53563000
Inventory turnover: 2.3048932630995287
Receivables turnover: 0.7333664883963465
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.7609679343120046
FCF margin (%): 3.9215785504987375
Revenue growth (%): 6.585001429411353
Rule of 40 score: 10.50657997991009